View in EDS HTML Full Text PDF Full Text

Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Saved in:
Bibliographic Details
Title: Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Authors: Shadman M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Salkar M; AbbVie, North Chicago, IL, USA., Srivastava B; AbbVie, North Chicago, IL, USA., Karve S; AbbVie, North Chicago, IL, USA., Emond B; Analysis Group, Inc., Montréal, Canada., Gogna P; Analysis Group, Inc., Montréal, Canada., Manceur AM; Analysis Group, Inc., Montréal, Canada., Lafeuille MH; Analysis Group, Inc., Montréal, Canada., Rava A; Genesis Research Group, Hoboken, NJ, USA., Sun H; Genesis Research Group, Hoboken, NJ, USA., Howarth A; Genesis Research Group, Hoboken, NJ, USA., Tomicki S; Genesis Research Group, Hoboken, NJ, USA., Agatep B; Inovalon, Bowie, MD, USA., Jones B; Inovalon, Bowie, MD, USA., Franceschini E; AbbVie, North Chicago, IL, USA., Saifan C; AbbVie, North Chicago, IL, USA., Bacchus S; AbbVie, North Chicago, IL, USA., Roeker L; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stephens DM; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jan; Vol. 66 (1), pp. 44-53. Date of Electronic Publication: 2024 Oct 01.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39352001
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shadman+M%22">Shadman M</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Salkar+M%22">Salkar M</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Srivastava+B%22">Srivastava B</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Karve+S%22">Karve S</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Emond+B%22">Emond B</searchLink>; Analysis Group, Inc., Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Gogna+P%22">Gogna P</searchLink>; Analysis Group, Inc., Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Manceur+AM%22">Manceur AM</searchLink>; Analysis Group, Inc., Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Lafeuille+MH%22">Lafeuille MH</searchLink>; Analysis Group, Inc., Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Rava+A%22">Rava A</searchLink>; Genesis Research Group, Hoboken, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Sun+H%22">Sun H</searchLink>; Genesis Research Group, Hoboken, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Howarth+A%22">Howarth A</searchLink>; Genesis Research Group, Hoboken, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Tomicki+S%22">Tomicki S</searchLink>; Genesis Research Group, Hoboken, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Agatep+B%22">Agatep B</searchLink>; Inovalon, Bowie, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jones+B%22">Jones B</searchLink>; Inovalon, Bowie, MD, USA.<br /><searchLink fieldCode="AU" term="%22Franceschini+E%22">Franceschini E</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Saifan+C%22">Saifan C</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Bacchus+S%22">Bacchus S</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Roeker+L%22">Roeker L</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2025 Jan; Vol. 66 (1), pp. 44-53. <i>Date of Electronic Publication: </i>2024 Oct 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39352001
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2024.2402814
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 44
    Titles:
      – TitleFull: Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shadman M
      – PersonEntity:
          Name:
            NameFull: Salkar M
      – PersonEntity:
          Name:
            NameFull: Srivastava B
      – PersonEntity:
          Name:
            NameFull: Karve S
      – PersonEntity:
          Name:
            NameFull: Emond B
      – PersonEntity:
          Name:
            NameFull: Gogna P
      – PersonEntity:
          Name:
            NameFull: Manceur AM
      – PersonEntity:
          Name:
            NameFull: Lafeuille MH
      – PersonEntity:
          Name:
            NameFull: Rava A
      – PersonEntity:
          Name:
            NameFull: Sun H
      – PersonEntity:
          Name:
            NameFull: Howarth A
      – PersonEntity:
          Name:
            NameFull: Tomicki S
      – PersonEntity:
          Name:
            NameFull: Agatep B
      – PersonEntity:
          Name:
            NameFull: Jones B
      – PersonEntity:
          Name:
            NameFull: Franceschini E
      – PersonEntity:
          Name:
            NameFull: Saifan C
      – PersonEntity:
          Name:
            NameFull: Bacchus S
      – PersonEntity:
          Name:
            NameFull: Roeker L
      – PersonEntity:
          Name:
            NameFull: Stephens DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1